DB
GH icon

Dmitry Balyasny’s Guardant Health GH Stock Holding History

Dmitry Balyasny’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,100
Closed -$1.13M – 3259
2025
Q3 		$1.13M Buy
18,100
+10,700
+145% +$582K ﹤0.01% 2063
2025
Q2 		$385K Buy
+7,400
New +$331K ﹤0.01% 2395
2024
Q4 		– Sell
-20,000
Closed -$459K – 2932
2024
Q3 		$459K Buy
+20,000
New +$566K ﹤0.01% 2296

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Dmitry Balyasny's GH Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Guardant Health (GH) in Q2 2026: 124,368 shares worth $18.7M. The stake represents 0.02% of the portfolio and ranks #754 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in GH as recently as Q4 2025.

Dmitry Balyasny first reported a position in GH in Q2 2020 and has held it in 21 quarters since. The position peaked at $53.4M in Q1 2022. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Dmitry Balyasny held 124,368 shares of Guardant Health worth $18.7M as of Q2 2026.
  • Guardant Health was a new Dmitry Balyasny position in Q2 2026.
  • Guardant Health made up 0.02% of Dmitry Balyasny's portfolio in Q2 2026, its #754 holding.
  • Dmitry Balyasny first reported a position in Guardant Health in Q2 2020 and has held it in 21 quarters since.
  • Dmitry Balyasny's Guardant Health position peaked at $53.4M in Q1 2022.
  • 595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.